Stronger Sell Today ADMS ranks #4072 as SELL CANDIDATE. Weaker Sell
Today ADMS ranks #4072 as SELL CANDIDATE.

ADMS stock Adamas Pharmaceuticals

ADMS stock
Adamas Pharmaceuticals

18 January 2019
Change 1.01%
Chart period: 2018-10-19 - 2019-01-18




Request Prediction

Adamas Pharmaceuticals Stock Analysis

Technical stock analysis for 18 January 2019

Sell candidate since 2019-01-18
Shorts n/a
Cash n/a
Loans n/a
Beta 1.45
ROA -66.94

Adamas Pharmaceuticals gained 1.01% in the last trading day, rising from $8.93 to $9.02 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 7 of the last 10 days and is down by -2.06% for this period. Volume fell in the last day by -224 545 shares, and in total, 323 563 shares bought and sold for approximately $2.92 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Friday, 18th Jan 2019) of the ADMS stock was $9.02. This is 1.01% more than the trading day before Thursday, 17th Jan 2019.

During day the stock fluctuated 4.35% from a day low at $8.74 to a day high of $9.12.

30 day high of the ADMS stock price was $10.65 and low was $7.42.
90 day high was $18.51 and low was $7.42.
52 week high for the Adamas Pharmaceuticals - $44.00 and low - $7.42.


Adamas Pharmaceuticals lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $10.01 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -45.23% during the next 3 months and, with 90% probability hold a price between $2.31 and $5.48 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Wednesday January 16, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Adamas Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $9.14. On a fall, the stock will find some support from the short-term average at $8.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $8.10 and $7.86.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adamas Pharmaceuticals finds support just below today's level at $8.10. If this is broken, then the next support from accumulated volume will be at $7.86 and $7.84.

Support: $8.10 Price: $9.02 Resistance: $9.62


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.38 between high and low, or 4.35%. For the last week, the stock has had a daily average volatility of 5.63%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Adamas Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Stronger Sell Today ADMS ranks #4072 as SELL CANDIDATE. Weaker Sell
Today ADMS ranks #4072 as SELL CANDIDATE.